Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

Engineered Facial Bone Grown from Stem Cells

Engineers developed techniques for growing personalized replacement facial bone from stem cells that in tests with pigs precisely fit their recipients’ faces. . . . → Read More: Engineered Facial Bone Grown from Stem Cells

Univ. of Pittsburgh, Ansys Partner on Additive Mfring

Ansys, a developer of engineering simulation software and services, is starting an additive manufacturing lab at University of Pittsburgh’s engineering school. . . . → Read More: Univ. of Pittsburgh, Ansys Partner on Additive Mfring

Graphene Chip Detects DNA, RNA Mutations

Biosensor chip with a double stranded DNA probe embedded on a graphene transistor (University of California, San Diego)

15 June 2016. A biomedical engineering team developed a chip built on graphene that detects mutations in genetic material, for eventual use in mobile diagnostics equipment. Researchers from University of California in San Diego, led . . . → Read More: Graphene Chip Detects DNA, RNA Mutations

Glucose Drug Reduces Heart Disease in People with Diabetes

(CIRM.gov)

14 June 2016. A drug to reduce glucose levels was shown in a clinical trial to reduce serious heart disease in people with type 2 diabetes also at high risk of heart disease. Results of the late-stage trial testing the drug liraglutide, marketed by drug-maker Novo Nordisk under the brand name Victoza, . . . → Read More: Glucose Drug Reduces Heart Disease in People with Diabetes

Trial Underway Testing Drug to Reduce Chronic Cough

High-resolution CT scan of lungs with idiopathic pulmonary fibrosis (IPF Editor, Wikimedia Commons)

14 June 2016. A clinical trial testing a drug treating chronic cough — coughs continuing for 8 weeks or more — will begin recruiting participants in the U.K. to join other sites in the U.S. The U.K. sites are under . . . → Read More: Trial Underway Testing Drug to Reduce Chronic Cough

Consortium Aims to Upgrade Cell Manufacturing

Microfluidic device to capture cancer cell clusters in blood samples (Rob Felt, Georgia Tech)

13 June 2016. A collaboration between businesses and universities outlined a strategy to develop processes and technologies for large-scale manufacturing of human cells for therapies and diagnostics. The National Cell Manufacturing Consortium, residing at Georgia Institute of Technology, announced . . . → Read More: Consortium Aims to Upgrade Cell Manufacturing

FDA Approves Cholera Vaccine

Clinic in Haiti treating cholera patients in 2010 (Kendra Helmer, USAID)

13 June 2016. Food and Drug Administration approved for marketing the U.S. a vaccine to prevent cholera for travelers to regions in the world where contaminated food or water is causing the disease. Vaxchora by PaxVax Inc. in Redwood City, California is . . . → Read More: FDA Approves Cholera Vaccine

Process Devised to Quickly Isolate Bacteria in Lab Samples

Scanning electron micrograph of Staphylococcus aureus bacteria (CDC.gov)

10 June 2016. A biomedical engineering center at Harvard University developed a process for quickly isolating staph bacteria from clinical samples for lab testing. The team led by Donald Ingber, director of the Wyss Institute for Biologically Inspired Engineering at Harvard, published its findings earlier . . . → Read More: Process Devised to Quickly Isolate Bacteria in Lab Samples

New Diabetic Eye Disease Drugs Shown Not Cost-Effective

(TBIT/Pixabay)

10 June 2016. An evaluation of two new biologic drugs to treat diabetic macular edema, an eye disease caused by diabetes, show the drugs do not provide enough additional benefit over much less expensive treatments to justify their higher price tags. The team led by Adam Glassman of the Jaeb Center for . . . → Read More: New Diabetic Eye Disease Drugs Shown Not Cost-Effective

Clinical Center, Mobile Developer Partner on Diabetes Apps

mySugr Diabetes Logbook app (mySugr GmbH)

9 June 2016. A clinical center specializing in metabolic disorders is collaborating with a designer of mobile diabetes software on research to upgrade and enhance the company’s apps. Financial terms of the agreement between Profil Institute for Clinical Research in Chula Vista, California and mySugr GmbH in . . . → Read More: Clinical Center, Mobile Developer Partner on Diabetes Apps